Experimental drug works of chronic leukemia

Druker said that all patients are treated in the studio, because we need to follow to determine the long-term benefits and side effects of this treatment. No one stopped because of medication side effects, he said. Side effects associated with treatment include stomach upset if the pills are taken on an empty stomach, and some muscle cramps have been reported.But for patients in the STI571 studies, their white blood cell count returned to normal if they were taking the right amounts of drugs – about four tablets once a day, according to researcher Brian Druker, MD. Druker, associate professor of medicine at Oregon Health Sciences University in Portland, has presented its findings at a meeting of cancer researchers here.

Health information tailored to the needs of people living with, fighting, and survival of cancer. Sign up for the WebMD Cancer newsletter trusted.

Known as STI571 research, drugs, taken orally, is designed to interfere with a key substance in the body that is necessary for the development of chronic myeloid leukemia . Approximately one third of the population are candidates for bone marrow, while the rest rely on drugs. The time of diagnosis, the average person will die within 4-6 years.

Patients are still in progress’ s, about eight to 10 months later, because if you look carefully in their bone marrow, you can still see evidence of leukemia, Druker WebMD. Patients in the study were diagnosed with CML for an average of three and a half years.

Doctors say that an experimental drug that has proven extremely successful at the beginning of leukemia control may also work in a rare but fatal, and fit.

Druker explained that STI571 was designed to stop the disease from progressing. He said that the pill also appears to be effective against brain cancer called glioblastoma, and small cell lung cancer e.

About 60 % of women who had RLS for a first pregnancy had the trouble again in a future pregnancy, compared with 3 % of women who do not have RLS during a first pregnancy, according to the report published in the December 7 journal Neurology.